No Picture
News

After serious side effect, Sarepta and FDA realign on next-gen Duchenne drug with trial hold lifted

FDA’s monthslong trial hold on Sarepta Therapeutics’ next-gen Duchenne muscular dystrophy drug is out the door after the biotech and regulator hashed out a new global trial protocol to expand monitoring of urine biomarkers. The US agency took notice in June after a serious adverse event of low magnesium levels… Click here to view original post… […]

No Picture
News

Restricted Stock Units (RSUs) or Stock Options? Which Choice is Right For You?

The types of equity grants being offered these days are different than what was offered in the past. Ten or 15 years ago, the vast majority of grants were in the form of stock options. Today, Restricted Stock Units (RSUs) are much more common. Many people within the life sciences… Click here to view original post… […]

No Picture
News

Theseus Pharmaceuticals to Participate at Upcoming September Investor Conferences

CAMBRIDGE, Mass., Sept. 6, 2022 /PRNewswire/ — Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative… Click here to view original post… […]

No Picture
News

Ventus Therapeutics Opens New Facility in Waltham, MA as First Phase of Global Expansion

WALTHAM, Mass. & MONTREAL–(BUSINESS WIRE)–Ventus Therapeutics, Inc., a biopharmaceutical company utilizing structural biology and a proprietary computational chemistry platform to identify and develop small molecule therapeutics across a broad range of diseases, announced today the opening of a new office and lab facility in Waltham, Massachusetts as the first phase… Click here to view original post… […]

No Picture
News

Trinity Life Sciences Announces the Appointment of Maia Germain as Chief People Officer

WALTHAM, Mass.–(BUSINESS WIRE)–Trinity Life Sciences, a global leader in life sciences solutions, today announced the appointment of Maia Germain as Chief People Officer (CPO) and a member of the executive operating committee, reporting directly to Rebecca McNamara, Trinity’s CFO and Head of Corporate Operations. Ms. Germain has a proven track… Click here to view original post… […]

No Picture
News

Leap Therapeutics Announces Appointment of Richard L. Schilsky, MD to its Board of Directors

CAMBRIDGE, Mass., Sept. 6, 2022 /PRNewswire/ — Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the appointment of Richard L. Schilsky, MD, FASCO, FACP, FSCT to its Board of Directors,… Click here to view original post… […]

No Picture
News

Omega Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

CAMBRIDGE, Mass., Sept. 6, 2022 /PRNewswire/ — Omega Therapeutics, Inc. (NASDAQ: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the first systematic approach to use mRNA therapeutics as a new class of programmable epigenetic medicines by leveraging its OMEGA… Click here to view original post… […]